Anyone else receive the new Oral OTC Medication testing email?

I received the attached Amazon notice stating that my oral OTC medication listings will be deactivated unless I submit the following:

• $1M commercial liability insurance
• third-party product testing through an Amazon-authorized TIC provider
• a surveillance testing agreement
• a penalty acknowledgment

I understand why Amazon has tightened compliance for dietary supplements.

What I am more curious about is why Amazon is now applying this framework to oral OTC drug products, including established OTC drug products that already exist within an FDA drug/regulatory framework, rather than just higher-risk supplement-type products.

I am curious if there is any differentiation or seperation out between USP Monograph products vs NDA/ANDA products – or if Amazon even understands this difference.

What I am trying to find out is:

• Has anyone else received this same notice?
• Has anyone already completed this process?
• What did Amazon actually require in practice?
• What exactly did the surveillance testing agreement turn out to mean?
• Is Amazon doing actual random post-listing lab pulls/testing?
• Has anyone successfully appealed products that were incorrectly classified into this requirement?

I’m especially interested in hearing from sellers dealing with actual OTC drug listings, not just supplements.